These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35936134)

  • 41. SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases.
    Khan M; Lin J; Liao G; Tian Y; Liang Y; Li R; Liu M; Yuan Y
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818798792. PubMed ID: 30213236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy.
    Ahmed KA; Stallworth DG; Kim Y; Johnstone PA; Harrison LB; Caudell JJ; Yu HH; Etame AB; Weber JS; Gibney GT
    Ann Oncol; 2016 Mar; 27(3):434-41. PubMed ID: 26712903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stereotactic Radiosurgery for Melanoma Brain Metastases: A Comprehensive Clinical Case Series.
    Feng R; Oermann EK; Shrivastava R; Gold A; Collins BT; Kondziolka D; Collins SP
    World Neurosurg; 2017 Apr; 100():297-304. PubMed ID: 28093345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
    Grandhi R; Kondziolka D; Panczykowski D; Monaco EA; Kano H; Niranjan A; Flickinger JC; Lunsford LD
    J Neurosurg; 2012 Aug; 117(2):237-45. PubMed ID: 22631694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery.
    Wolf A; Kvint S; Chachoua A; Pavlick A; Wilson M; Donahue B; Golfinos JG; Silverman J; Kondziolka D
    J Neurosurg; 2018 Jan; 128(1):23-31. PubMed ID: 28298015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stereotactic radiosurgery for brain metastases from malignant melanoma.
    Christ SM; Mahadevan A; Floyd SR; Lam FC; Chen CC; Wong ET; Kasper EM
    Surg Neurol Int; 2015; 6(Suppl 12):S355-65. PubMed ID: 26392919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of Brain Metastases in the New Era of Checkpoint Inhibition.
    Lauko A; Thapa B; Venur VA; Ahluwalia MS
    Curr Neurol Neurosci Rep; 2018 Aug; 18(10):70. PubMed ID: 30121715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity.
    Rahman R; Cortes A; Niemierko A; Oh KS; Flaherty KT; Lawrence DP; Sullivan RJ; Shih HA
    J Neurooncol; 2018 Jun; 138(2):299-306. PubMed ID: 29453679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma.
    Stera S; Balermpas P; Blanck O; Wolff R; Wurster S; Baumann R; Szücs M; Loutfi-Krauss B; Wilhelm ML; Seifert V; Rades D; Rödel C; Dunst J; Hildebrandt G; Arnold A; Meissner M; Kähler KC
    Melanoma Res; 2019 Apr; 29(2):187-195. PubMed ID: 30802230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery.
    Bian SX; Routman D; Liu J; Yang D; Groshen S; Zada G; Trakul N; Wong MK; Yu C; Chang EL
    J Neurosurg; 2016 Dec; 125(Suppl 1):31-39. PubMed ID: 27903181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stereotactic radiosurgery combined with anti-PD1 for the management of melanoma brain metastases: A retrospective study of safety and efficacy.
    Carron R; Gaudy-Marqueste C; Amatore F; Padovani L; Malissen N; Balossier A; Loundou A; Bonnet N; Muracciole X; Régis JM; Grob JJ
    Eur J Cancer; 2020 Aug; 135():52-61. PubMed ID: 32535348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salvage Stereotactic Radiosurgery in Breast Cancer Patients with Multiple Brain Metastases.
    Perez JL; Ozpinar A; Kano H; Phan B; Niranjan A; Lunsford LD
    World Neurosurg; 2019 May; 125():e479-e486. PubMed ID: 30710716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy.
    Burke AM; Carrasquilla M; Jean WC; Collins BT; Anaizi AN; Atkins MB; Gibney GT; Collins SP
    Front Oncol; 2021; 11():794615. PubMed ID: 35096594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases.
    Patel KR; Shoukat S; Oliver DE; Chowdhary M; Rizzo M; Lawson DH; Khosa F; Liu Y; Khan MK
    Am J Clin Oncol; 2017 Oct; 40(5):444-450. PubMed ID: 26017484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence of Intracranial Melanoma Progression in the Setting of Positive Extracranial Response to Targeted Therapy and Immunotherapy: An Indication for More Frequent Screening in This Population?
    Gattozzi DA; Rosso C; Schatmeyer BA; Kabangu JK; Doolittle GC; Wang F; Stepp T
    Cureus; 2021 Mar; 13(3):e13648. PubMed ID: 33824801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery.
    Tazi K; Hathaway A; Chiuzan C; Shirai K
    Cancer Med; 2015 Jan; 4(1):1-6. PubMed ID: 25164960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.
    Fang P; Jiang W; Allen P; Glitza I; Guha N; Hwu P; Ghia A; Phan J; Mahajan A; Tawbi H; Li J
    J Neurooncol; 2017 Jul; 133(3):595-602. PubMed ID: 28500560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.